Abstract
Allergen immunotherapy is effective in rhinitis and astma. It decreases the risk of asthma and risk of polysenzitization.
Future immunotherapeutic approaches are represented by anti-IgE monoclonal antibody for example.
Allergen immunotherapy is effective in rhinitis and astma. It decreases the risk of asthma and risk of polysenzitization.
Future immunotherapeutic approaches are represented by anti-IgE monoclonal antibody for example.